The SMC5/6 complex maintains telomere length in ALT cancer cells through SUMOylation of telomere-binding proteins

Nature Structural and Molecular Biology

Volumn 14, Issue 7, 2007, Pages 581-590

  Potts, Patrick Ryan ^a   Yu, Hongtao ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGASE; TELOMERASE; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; TELOMERIC REPEAT BINDING FACTOR 2;

ARTICLE; CANCER CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; RNA INTERFERENCE; SENESCENCE; SUMOYLATION; TELOMERE;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; HUMANS; LIGASES; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINATION, GENETIC; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 34447129654     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb1259     Document Type: Article

References (55)

1. Blackburn, E.H. Switching and signaling at the telomere. Cell 106, 661-673 (2001).
2. Harley, C.B., Futcher, A.B. & Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460 (1990).
3. Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
4. Smogorzewska, A. & de Lange, T. Regulation of telomerase by telomeric proteins. Annu. Rev. Biochem. 73, 177-208 (2004).
5. Cong, Y.S., Wright, W.E. & Shay, J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66, 407-425 (2002).
6. Shay, J.W. & Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791 (1997).
7. Bryan, T.M., Englezou, A., Dalla-Pozza, L., Dunham, M.A. & Reddel, R.R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med. 3, 1271-1274 (1997).
8. Henson, J.D. et al. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin. Cancer Res. 11, 217-225 (2005).
9. Bryan, T.M., Englezou, A., Gupta, J., Bacchetti, S. & Reddel, R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248 (1995).
10. Muntoni, A. & Reddel, R.R. The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 14, R191-R196 (2005).
11. Henson, J.D., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Alternative lengthening of telomeres in mammalian cells. Oncogene 21, 598-610 (2002).
12. Lundblad, V. & Blackburn, E.H. An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73, 347-360 (1993).
13. Dunham, M.A., Neumann, A.A., Fasching, C.L. & Reddel, R.R. Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450 (2000).
14. Londono-Vallejo, J.A., Der-Sarkissian, H., Cazes, L., Bacchetti, S. & Reddel, R.R. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res. 64, 2324-2327 (2004).
15. Rogan, E.M. et al. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol. 15, 4745-4753 (1995).
16. Yeager, T.R. et al. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179 (1999).
17. Perrem, K., Colgin, L.M., Neumann, A.A., Yeager, T.R. & Reddel, R.R. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell. Biol. 21, 3862-3875 (2001).
18. Grobelny, J.V., Godwin, A.K. & Broccoli, D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J. Cell Sci. 113, 4577-4585 (2000).
19. Johnson, F.B. et al. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20, 905-913 (2001).
20. Nabetani, A., Yokoyama, O. & Ishikawa, F. Localization of hRad9, hHus1, hRad1, and hRad17 and caffeine-sensitive DNA replication at the alternative lengthening of telomeres-associated promyelocytic leukemia body. J. Biol. Chem. 279, 25849-25857 (2004).
21. Yankiwski, V., Marciniak, R.A., Guarente, L. & Neff, N.F. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA 97, 5214-5219 (2000).
22. Zhu, X.D., Kuster, B., Mann, M., Petrini, J.H. & de Lange, T. Cell-cycle-regulated association of RAD50/MRE11/NBS1 with TRF2 and human telomeres. Nat. Genet. 25, 347-352 (2000).
23. Wu, G., Jiang, X., Lee, W.H. & Chen, P.L. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res. 63, 2589-2595 (2003).
24. Jiang, W.Q. et al. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol. Cell. Biol. 25, 2708-2721 (2005).
25. Hirano, T. SMC proteins and chromosome mechanics: from bacteria to humans. Phil. Trans. R. Soc. Lond. B 360, 507-514 (2005).
26. Koshland, D.E. & Guacci, V. Sister chromatid cohesion: the beginning of a long and beautiful relationship. Curr. Opin. Cell Biol. 12, 297-301 (2000).
27. Swedlow, J.R. & Hirano, T. The making of the mitotic chromosome: modern insights into classical questions. Mol. Cell 11, 557-569 (2003).
28. Lehmann, A.R. The role of SMC proteins in the responses to DNA damage. DNA Repair (Amst.) 4, 309-314 (2005).
29. Lehmann, A.R. et al. The rad18 gene of Schizosaccharomyces pombe defines a new subgroup of the SMC superfamily involved in DNA repair. Mol. Cell. Biol. 15, 7067-7080 (1995).
30. Verkade, H.M., Bugg, S.J., Lindsay, H.D., Carr, A.M. & O'Connell, M.J. Rad18 is required for DNA repair and checkpoint responses in fission yeast. Mol. Biol. Cell 10, 2905-2918 (1999).
31. Torres-Rosell, J. et al. SMC5 and SMC6 genes are required for the segregation of repetitive chromosome regions. Nat. Cell Biol. 7, 412-419 (2005).
32. Lee, K.M. & O'Connell, M.J. A new SUMO ligase in the DNA damage response. DNA Repair (Amst.) 5, 138-141 (2006).
33. Muller, S., Hoege, C., Pyrowolakis, G. & Jentsch, S. SUMO, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2, 202-210 (2001).
34. Potts, P.R. & Yu, H. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol. Cell. Biol. 25, 7021-7032 (2005).
35. Zhao, X. & Blobel, G.A. SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl. Acad. Sci. USA 102, 4777-4782 (2005).
36. Potts, P.R., Porteus, M.H. & Yu, H. Human SMC5/6 complex promotes sister chromatid homologous recombination by recruiting the SMC1/3 cohesin complex to double-strand breaks. EMBO J. 25, 3377-3388 (2006).
37. De Piccoli, G. et al. Smc5-Smc6 mediate DNA double-strand-break repair by promoting sister-chromatid recombination. Nat. Cell Biol. 8, 1032-1034 (2006).
38. Lindroos, H.B. et al. Chromosomal association of the Smc5/6 complex reveals that it functions in differently regulated pathways. Mol. Cell 22, 755-767 (2006).
39. Onoda, F. et al. SMC6 is required for MMS-induced interchromosomal and sister chromatid recombinations in Saccharomyces cerevisiae. DNA Repair (Amst.) 3, 429-439 (2004).
40. Wright, W.E., Pereira-Smith, O.M. & Shay, J.W. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol. 9, 3088-3092 (1989).
41. Laud, P.R. et al. Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev. 19, 2560-2570 (2005).
42. de Lange, T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 19, 2100-2110 (2005).
43. Gocke, C.B., Yu, H. & Kang, J. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 280, 5004-5012 (2005).
44. Lin, D.Y. et al. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol. Cell 24, 341-354 (2006).
45. Rodriguez, M.S., Dargemont, C. & Hay, R.T. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J. Biol. Chem. 276, 12654-12659 (2001).
46. Xhemalce, B. et al. Role of SUMO in the dynamics of telomere maintenance in fission yeast. Proc. Natl. Acad. Sci. USA 104, 893-898 (2007).
47. Maul, G.G., Negorev, D., Bell, P. & Ishov, A.M. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J. Struct. Biol. 129, 278-287 (2000).
48. Borden, K.L. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269 (2002).
49. Wu, G., Lee, W.H. & Chen, P.L. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. Implication of NBS1 in alternative lengthening of telomeres. J. Biol. Chem. 275, 30618-30622 (2000).
50. Seeler, J.S. & Dejean, A. SUMO: of branched proteins and nuclear bodies. Oncogene 20, 7243-7249 (2001).
51. Ishov, A.M. et al. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234 (1999).
52. Ampatzidou, E., Irmisch, A., O'Connell, M.J. & Murray, J.M. Smc5/6 is required for repair at collapsed replication forks. Mol. Cell. Biol. 26, 9387-9401 (2006).
53. Branzei, D. et al. Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks. Cell 127, 509-522 (2006).
54. Miyabe, I., Morishita, T., Hishida, T., Yonei, S. & Shinagawa, H. Rhp51-dependent recombination intermediates that do not generate checkpoint signal are accumulated in Schizosaccharomyces pombe rad60 and smc5/6 mutants after release from replication arrest. Mol. Cell. Biol. 26, 343-353 (2006).
55. Wang, R.C., Smogorzewska, A. & de Lange, T. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119, 355-368 (2004).